178 related articles for article (PubMed ID: 17549315)
1. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
Lippi G; Franchini M; Targher G
Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
[No Abstract] [Full Text] [Related]
2. Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?
Fateh-Moghadam S; Gawaz M
Thromb Haemost; 2007 Feb; 97(2):169-70. PubMed ID: 17264941
[No Abstract] [Full Text] [Related]
3. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Smout J; Cleanthis M; Stansby G
Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
[No Abstract] [Full Text] [Related]
4. Platelet activation by collagen is increased in retinal vein occlusion.
Leoncini G; Bruzzese D; Signorello MG; Armani U; Piana A; Ghiglione D; Camicione P
Thromb Haemost; 2007 Feb; 97(2):218-27. PubMed ID: 17264950
[TBL] [Abstract][Full Text] [Related]
5. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
6. The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring.
Harrison P
Thromb Res; 2010 Aug; 126(2):e137-8. PubMed ID: 19931889
[No Abstract] [Full Text] [Related]
7. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
9. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
10. Aspirin response variability assessed with the PFA-100 device.
Reny JL; Quéré I; de Moerloose P; Fontana P
Thromb Haemost; 2008 May; 99(5):968-9; author reply 969. PubMed ID: 18449432
[No Abstract] [Full Text] [Related]
11. Is the antiplatelet effect of aspirin affected by systemic inflammation?
Poulsen TS; Mickley H
Ann Hematol; 2004 Nov; 83(11):728. PubMed ID: 15338199
[No Abstract] [Full Text] [Related]
12. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
13. Platelet activity and outcome after intracerebral hemorrhage.
Naidech AM; Bernstein RA; Levasseur K; Bassin SL; Bendok BR; Batjer HH; Bleck TP; Alberts MJ
Ann Neurol; 2009 Mar; 65(3):352-6. PubMed ID: 19334079
[TBL] [Abstract][Full Text] [Related]
14. Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men.
Hjorth Madsen E; Christiansen MK; Schmidt EB; Poulsen TS; Kristensen SR
Platelets; 2009 May; 20(3):177-82. PubMed ID: 19437335
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
Mani H; Lindhoff-Last E
Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
[No Abstract] [Full Text] [Related]
16. [Monitoring of antiplatelet drug effects--fashion or necessity?].
Kuliczkowski W; Zembala M; Poloński L; Kaczmarski J; Gasior M
Kardiol Pol; 2008 Jan; 66(1):119-24. PubMed ID: 18266199
[No Abstract] [Full Text] [Related]
17. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
18. A shortcut to peptides to modulate platelets.
Apic G; Russell RB
Nat Chem Biol; 2007 Feb; 3(2):83-4. PubMed ID: 17235341
[No Abstract] [Full Text] [Related]
19. The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.
Warner TD; Armstrong PC; Chan MV; Knowles RB
Expert Rev Hematol; 2016 Mar; 9(3):223-5. PubMed ID: 26822235
[No Abstract] [Full Text] [Related]
20. Aspirin resistance and atherothrombotic disease.
Maree AO; Jneid H; Fitzgerald DJ
J Am Coll Cardiol; 2006 Aug; 48(4):846-7; author reply 847. PubMed ID: 16904562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
